NEW YORK, March 2 - U.S. stock index futures were little changed on Monday, after the S&P 500 scored its best monthly performance in more than three years and ahead of data on the consumer and manufacturing sector.
* Dismisses Dmitry Sovetkin from general director post and appoints to this post Elena Bushberg as of Feb. 28 Source text: http://bit.ly/1B18n0g Further company coverage: (Gdynia Newsroom)
March 2 - The U.S. Food and Drug Administration rejected Pacira Pharmaceuticals Inc's application for expanding the use of its post-surgery pain drug, Exparel.
March 2 - Boston Scientific Corp said it will acquire Endo International Plc's American Medical Systems urology portfolio for up to $1.65 billion.
March 2 - Manufacturers' tests of procedures to clean medical scopes linked with "superbug" outbreaks contained flaws that render their cleaning instructions unreliable, according to a senior official with the U.S. Food and Drug Administration.
MUMBAI/NEW DELHI - India has formally adopted inflation targeting, a historic monetary policy overhaul that marks a victory for Reserve Bank of India Governor Raguram Rajan, as the government makes subduing chronically volatile prices a priority.